Statements (45)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:pharmaceuticals
|
gptkbp:acquisition |
gptkb:Gavis_Pharmaceuticals
gptkb:Merck_KGa_A's_generics_business |
gptkbp:awards |
gptkb:Best_CSR_Practices_Award
Best Employer Award Innovation in Pharma Award Excellence in R& D Award Pharma Company of the Year |
gptkbp:employees |
over 20,000
|
gptkbp:founded |
gptkb:1968
|
gptkbp:founder |
gptkb:Desh_Bandhu_Gupta
|
gptkbp:headquarters |
gptkb:Mumbai,_India
|
https://www.w3.org/2000/01/rdf-schema#label |
Lupin Pharmaceuticals
|
gptkbp:market |
antibiotics
cardiovascular drugs women's health products diabetes medications dermatology products respiratory products gastrointestinal drugs oncology products pediatric products central nervous system drugs |
gptkbp:operates_in |
over 100 countries
|
gptkbp:partnership |
various healthcare organizations
|
gptkbp:products |
generic drugs
branded drugs |
gptkbp:regulatory_compliance |
gptkb:MHRA
gptkb:FDA gptkb:EMA TGA |
gptkbp:research_and_development |
focus on chronic diseases
|
gptkbp:revenue |
$2.1 billion (2021)
|
gptkbp:subsidiary |
gptkb:Lupin_Limited
|
gptkbp:sustainability_initiatives |
gptkb:waste_management
community engagement energy efficiency ethical sourcing water conservation employee welfare supply chain transparency environmental responsibility |
gptkbp:website |
www.lupin.com
|
gptkbp:bfsParent |
gptkb:Pfizer
|
gptkbp:bfsLayer |
4
|